Caricamento...
Development of a novel patient-reported measure for acromegaly: the Acro-TSQ
PURPOSE: Somatostatin analogs (SSAs) represent a mainstay of medical treatment for acromegaly, currently available as either intramuscular or deep subcutaneous injections. Patient-reported outcomes (PROs) are increasingly common as relevant outcomes in studies of acromegaly and its treatment, but th...
Salvato in:
| Pubblicato in: | Pituitary |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer US
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6842345/ https://ncbi.nlm.nih.gov/pubmed/31522359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11102-019-00986-4 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|